The global landscape of the **Organoids and Spheroids Market** is currently dominated by North America, but dynamic shifts in technological adoption are rapidly reshaping the competitive balance. North America's market leadership is secured by several deeply entrenched advantages: vast R&D budgets allocated by major pharmaceutical companies and leading academic institutions, a strong...